Business Context and Reporting Period
Company: Research Solutions, Inc. (RSSS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended June 30, 2025
Business Overview: A vertical software-as-a-service (SaaS) and artificial intelligence (AI) company providing research intelligence platforms (Discovery, Access, Manage) and transactional delivery of scientific, technical, and medical (STM) content. The company operates as a single segment and is fully remote.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Total Revenue | $49,057,981 | $44,623,899 |
| Gross Profit | $24,195,951 | $19,640,166 |
| Gross Margin | 49.3% | 44.0% |
| Net Income (Loss) | $1,265,553 | $(3,786,597) |
| Operating Cash Flow | $7,023,166 | $3,550,954 |
| Cash and Equivalents (End of Period) | $12,227,312 | $6,100,031 |
| Debt | $0 (No outstanding borrowings) | $0 |
| Contingent Earnout Liability | $14,046,640 | $12,298,114 |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $1.27 million in FY2025, reversing a net loss of $3.79 million in FY2024. This was driven by a $4.56 million increase in gross profit and a $1.49 million reduction in the change in fair value of the contingent earnout liability.
- Revenue Growth: Total revenue increased 9.9% year-over-year. Platform revenue grew 35.8% to $18.96 million, driven by new deployments and the full-year impact of the Scite acquisition. Transaction revenue declined slightly by 1.8% to $30.10 million due to lower order volumes.
- Operating Expenses: Sales and marketing expenses increased 55.7% to $5.36 million, primarily due to personnel costs associated with the Scite acquisition and a new Chief Revenue Officer. General and administrative expenses decreased 6.8% due to lower legal fees.
- Liquidity: Cash and cash equivalents doubled to $12.23 million, fueled by strong operating cash flow of $7.02 million.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the improved financial performance to increased gross profit and the favorable revaluation of the Scite acquisition earnout liability. The company continues to invest in AI-driven discovery tools and expanding its customer base in life sciences and academic sectors.
Risks and Contingencies:
- Contingent Earnout Liability: A significant liability of $14.05 million exists related to the Scite acquisition. Fluctuations in the fair value of this liability significantly impact net income. Subsequent events indicate the earnout was finalized at $15.4 million in July 2025, payable in cash and stock installments through May 2027.
- Supplier Concentration: Approximately 45% of content costs are derived from the three largest suppliers. Loss of these relationships would materially impact operations.
- Profitability History: Despite the current year profit, the company has an accumulated deficit of $25.04 million and historically relies on financing activities. Future profitability is not guaranteed.
- AI and Cybersecurity: The company faces risks related to the use of Generative AI, including data privacy, intellectual property claims, and cybersecurity threats.
Investor Verification Checklist
- Earnout Liability Valuation: Verify the assumptions used to value the $14.05 million contingent earnout liability and the impact of the subsequent $15.4 million finalization on future cash flows.
- Platform vs. Transaction Mix: Monitor the shift in revenue mix toward higher-margin Platform subscriptions versus lower-margin Transactional content.
- Supplier Agreements: Review the status of contracts with the top three content suppliers representing 45% of costs.
- Stock Repurchases: Note the company repurchased $934,577 of stock in FY2025; verify remaining authorization ($162,316) and future buyback plans.
- Internal Controls: Confirm the effectiveness of internal controls over financial reporting, particularly regarding the valuation of acquired intangible assets and earnout liabilities.